Sabra Health Care REIT Inc（SBRA）資訊與事件SBRASabra Health Care REIT Inc

Sabra Reports Q2 Revenue of $235.866M, Beating Expectations

Reports Q2 revenue $235.866M, consensus $219.46M. Commenting on the second quarter's results, Rick Matros, CEO and Chair, said, "Sabra delivered another solid quarter. Our same-store managed portfolio cash NOI growth continued to be healthy. Both our consolidated and unconsolidated managed portfolio came in with strong margin growth as well as increased occupancy. Our triple-net skilled nursing portfolio rent coverage increased yet again. The triple-net senior housing portfolio saw drops in occupancy and coverage simply due to the conversion of a high-performing triple-net asset to the managed portfolio. Otherwise, it would have been flat. In aggregate, our top ten tenants again showed increased coverage."

FY26 Guidance: Net Income $0.37 - $0.39

FY26 guidance: Net Income: $0.37 - $0.39, FFO: $1.12 - $1.14, Normalized FFO: $1.53 - $1.55, AFFO: $1.58 - $1.60, Normalized AFFO: $1.59 - $1.61

Sabra Signs LOIs with Cascadia Healthcare, Annual Rent Increases to $53 Million

Sabra has entered into letters of intent to re-tenant all of its 26 properties leased to Avamere. Under the proposed transition, 22 properties would be transitioned to subsidiaries of Cascadia Healthcare. Upon closing, the combined annualized cash rent of this portfolio is expected to be $53 million, a nearly 30% increase compared to the $41 million of cash rent received from Avamere during the trailing-twelve-month period ending March 31, 2026. The transition is expected to be completed during the second half of 2026. Commenting on the business update, Rick Matros, CEO and Chair, said, "We are pleased to announce this positive business update which highlights the execution of our strategy to increase shareholder value through enhanced portfolio quality, improved earnings growth and a focus on investing in our core senior housing and skilled nursing segments. These efforts have allowed us to increase our full-year 2026 guidance; at the midpoint, Normalized FFO and Normalized AFFO per share are now expected to increase by 7% and 8%, respectively, over 2025.